Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2291]
News [4641]
Articles [192]
Editorials [8]
Conferences [136]
elearning [9]
Chemotherapy combination with capecitabine extends survival after pancreatic...
Prof John Neoptolemos - University of Liverpool, Liverpool, UK
Chemotherapy combination with capecitabine extends survival after pancreatic cancer surgery ( Prof John Neoptolemos - University of Liverpool, Liverpool, UK )
5 Jun 2016
Patient engagement in The Metastatic Breast Cancer Project
Dr Nikhil Wagle - Dana-Farber Cancer Institute, Boston, USA
Patient engagement in The Metastatic Breast Cancer Project ( Dr Nikhil Wagle - Dana-Farber Cancer Institute, Boston, USA )
4 Jun 2016
Use of novel agents in childhood ALL
Prof Lia Gore - Children's Hospital Colarado, Aurora, USA
Use of novel agents in childhood ALL ( Prof Lia Gore - Children's Hospital Colarado, Aurora, USA )
6 May 2016
Radiotherapy in Hogkin lymphoma: reducing risk in later life
Dr Graham Collins - Oxford University Hospitals NHS Foundation Trust, Oxford, UK
Radiotherapy in Hogkin lymphoma: reducing risk in later life ( Dr Graham Collins - Oxford University Hospitals NHS Foundation Trust, Oxford, UK )
6 May 2016
Relapsed Hodgkin lymphoma in PET positive patients
Dr Graham Collins - Oxford University Hospitals NHS Foundation Trust, Oxford, UK
Relapsed Hodgkin lymphoma in PET positive patients ( Dr Graham Collins - Oxford University Hospitals NHS Foundation Trust, Oxford, UK )
6 May 2016
Entrectinib, a novel treatment for TRK fusions, shows early promise against a...
Dr Alexander Drilon - Memorial Sloan Kettering Cancer Center, New York, USA
Entrectinib, a novel treatment for TRK fusions, shows early promise against a range of cancer types ( Dr Alexander Drilon - Memorial Sloan Kettering Cancer Center, New York, USA )
6 May 2016
A presurgery combination therapy may improve outcomes for women with Her2...
Dr Angela DeMichele - Perelmen School of Medicine, University of Pennsylvania...
A presurgery combination therapy may improve outcomes for women with Her2-positive breast cancer ( Dr Angela DeMichele - Perelmen School of Medicine, University of Pennsylvania, Philadelphia, USA )
6 May 2016
5 year survival rates for nivolumab-treated metastatic melanoma patients much...
Dr Stephen Hodi - Dana-Farber Cancer Institute, Boston, USA
5 year survival rates for nivolumab-treated metastatic melanoma patients much higher than historical rates ( Dr Stephen Hodi - Dana-Farber Cancer Institute, Boston, USA )
6 May 2016
CD4 T-cell immunotherapy targeting MAGE-A3 is safe, and shows early clinical...
Dr Yong-Chen William Lu - National Cancer Institute, Bethesda, USA
CD4 T-cell immunotherapy targeting MAGE-A3 is safe, and shows early clinical responses ( Dr Yong-Chen William Lu - National Cancer Institute, Bethesda, USA )
6 May 2016
New investigational targeted therapeutic, entrectinib, shows early promise
Dr Alexander Drilon - Memorial Sloan Kettering Cancer Center, New York, USA
New investigational targeted therapeutic, entrectinib, shows early promise ( Dr Alexander Drilon - Memorial Sloan Kettering Cancer Center, New York, USA )
5 May 2016
Paediatric and adult high grade gliomas: A tale of a histone tail
Dr Nada Jabado - McGill University, Montreal, Canada
Paediatric and adult high grade gliomas: A tale of a histone tail ( Dr Nada Jabado - McGill University, Montreal, Canada )
5 May 2016
Galectins in tumour immunity
Dr Gabriel Rabinovich - Instituto de Biología y Medicina Experimental, Buenos...
Galectins in tumour immunity ( Dr Gabriel Rabinovich - Instituto de Biología y Medicina Experimental, Buenos Aires, Argentina )
5 May 2016

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation